Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.
Tools
Tools
Tools
Wright, T J, McKee, C, Birch-Machin, M A, Ellis, R, Armstrong, Jane and Lovat, P E (2013) Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy. Clinical and Experimental Dermatology. ISSN 1365-2230
Full text not available from this repository.
Official URL: http://onlinelibrary.wiley.com/doi/10.1111/ced.121...
| Item Type: | Article |
|---|---|
| Subjects: | Sciences > Pharmacy and Pharmacology |
| Divisions: | Faculty of Health Sciences and Wellbeing Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences Faculty of Health Sciences and Wellbeing > School of Nursing and Health Sciences |
| Depositing User: | Glenda Young |
| Date Deposited: | 18 Apr 2013 11:08 |
| Last Modified: | 18 Dec 2019 15:35 |
| URI: | http://sure.sunderland.ac.uk/id/eprint/3804 |
Actions (login required)
 |
View Item |
Altmetric